Literature DB >> 24709469

Late-onset neonatal group B streptococcal disease associated with breast milk transmission: molecular typing using RAPD-PCR.

Micaela Brandolini1, Marta Corbella2, Patrizia Cambieri2, Daniela Barbarini2, Davide Sassera3, Mauro Stronati4, Piero Marone2.   

Abstract

Group B Streptococcus (GBS) is considered to be the major cause of neonatal sepsis and meningitis of bacterial origin. Late-onset GBS infection is infrequent and occurs between 1 week and 3 months of age. The transmission of GBS through the ingestion of breast milk is reported in the literature, but only a few of these cases have been confirmed by molecular techniques. In this article we report five cases of late-onset GBS disease: transmission through maternal milk was confirmed in four cases, using the random amplified polymorphic DNA polymerase chain reaction (RAPD-PCR) typing assay. In addition, the RAPD-PCR assay showed that each of the isolated clones belonged to a different RAPD genotype, thus revealing that the late-onset GBS infections were not epidemiologically related.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast milk transmission; Group B streptococcal disease; Random amplified polymorphic DNA (RAPD)

Mesh:

Year:  2014        PMID: 24709469     DOI: 10.1016/S0378-3782(14)70025-8

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  7 in total

1.  Modification of the CpsA protein reveals a role in alteration of the Streptococcus agalactiae cell envelope.

Authors:  Hannah M Rowe; Brett R Hanson; Donna L Runft; Qian Lin; Steve M Firestine; Melody N Neely
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 2.  Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets.

Authors:  Lucy L Furfaro; Barbara J Chang; Matthew S Payne
Journal:  Clin Microbiol Rev       Date:  2018-08-15       Impact factor: 26.132

3.  Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B Streptococcus.

Authors:  Dorothy L Ackerman; Ryan S Doster; Jörn-Hendrik Weitkamp; David M Aronoff; Jennifer A Gaddy; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-06-13       Impact factor: 5.084

Review 4.  Challenges in reducing group B Streptococcus disease in African settings.

Authors:  Yo Nishihara; Ziyaad Dangor; Neil French; Shabir Madhi; Robert Heyderman
Journal:  Arch Dis Child       Date:  2016-10-18       Impact factor: 3.791

5.  Serial Clustering of Late-Onset Group B Streptococcal Infections in the Neonatal Unit: A Genomic Re-evaluation of Causality.

Authors:  Elita Jauneikaite; Georgia Kapatai; Frances Davies; Ioana Gozar; Juliana Coelho; Kathleen B Bamford; Benedetto Simone; Lipi Begum; Shannon Katiyo; Bharat Patel; Peter Hoffman; Theresa Lamagni; Eimear T Brannigan; Alison H Holmes; Tokozani Kadhani; Tracey Galletly; Kate Martin; Hermione Lyall; Yimmy Chow; Sunit Godambe; Victoria Chalker; Shiranee Sriskandan
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

6.  Prevalence of oropharyngeal group B Streptococcus colonization in mothers, family, and health care providers.

Authors:  Kristina Roloff; Gohar Stepanyan; Guillermo Valenzuela
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

7.  RAPD PCR detects co-colonisation of multiple group B streptococcus genotypes: A practical molecular technique for screening multiple colonies.

Authors:  Ka-Ning To; Oliver Powell; Dorota Jamrozy; Rachel Kopunova; Kyriaki Anastasiadou; Amadou Faal; Ousman Secka; Victoria Chalker; Kirsty Le Doare; Elita Jauneikaite
Journal:  J Microbiol Methods       Date:  2021-09-20       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.